KFF Health News October 9, 2024
Arthur Allen

Most employers have little idea what the pharmacy benefit managers they hire do with the money they exchange for the medications used by their employees, according to a KFF survey released Wednesday morning.

In KFF’s latest employer health benefits survey, company officials were asked how much of the rebates collected from drugmakers by pharmacy benefit managers, or PBMs, is returned to them. In recent years, the pharmaceutical industry has tried to deflect criticism of high drug prices by saying much of that income is siphoned off by the PBMs, companies that manage patients’ drug benefits on behalf of employers and health plans.

PBM leaders say they save companies and patients billions of dollars annually by obtaining rebates from drugmakers that...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Employer, Pharma, Pharma / Biotech, Survey / Study, Trends
GLP-1 drug coverage for obesity making inroads with large employers: Mercer
44% of large employers cover weight loss drugs for obesity: Mercer
Weight-loss Drug Coverage Rises Among Largest US Employers, Mercer Survey Finds
Most American adults qualify for semaglutide. Will employers cover the cost?
How AI Is Reshaping Industries And Creating Tomorrow’s Job Market

Share This Article